Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Chiarion Sileni

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|June 13, 2015
Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialA M M Eggermont, V Chiarion-Sileni, J-J Grob
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatinF Figoli, V Chiarion Sileni, M Gulisano, et al.
Clinical and Experimental Dermatology|September 26, 2009
Anetoderma in cutaneous marginal-zone B-cell lymphomaE Zattra, B Pigozzi, M Bordignon, et al.
Ecancermedicalscience|July 31, 2014
Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013A Testori, P Ascierto, V Chiarion Sileni, et al.
Immunopharmacology and Immunotoxicology|March 7, 2012
Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapyS M L Aversa, S Zanon, D Marino, et al.
British Journal of Cancer|April 28, 2006
Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancerG L Banna, S M L Aversa, G Crivellari, et al.
Cancer Treatment Reports|May 1, 1982
Vindesine overdoseM V Fiorentino, L Salvagno, V Chiarion Sileni, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
Treatment of multiple myeloma with M-2 protocol and without maintenance therapyA Paccagnella, G Cartei, V Fosser, et al.
Tumori|June 30, 1984
Urinary hydroxyproline in multiple myeloma: correlation with clinical stages and bone diseaseS Bolzonella, A Paccagnella, L Salvagno, et al.
Tumori|December 31, 1985
Vindesine in plasma cell tumorsL Salvagno, A Paccagnella, V Chiarion Sileni, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|June 13, 2015
Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trialA M M Eggermont, V Chiarion-Sileni, J-J Grob
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Leucovorin calcium enhancement of mucositis after continuous infusion fluorouracil and short infusion cisplatinF Figoli, V Chiarion Sileni, M Gulisano, et al.
Clinical and Experimental Dermatology|September 26, 2009
Anetoderma in cutaneous marginal-zone B-cell lymphomaE Zattra, B Pigozzi, M Bordignon, et al.
Ecancermedicalscience|July 31, 2014
Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013A Testori, P Ascierto, V Chiarion Sileni, et al.
Immunopharmacology and Immunotoxicology|March 7, 2012
Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapyS M L Aversa, S Zanon, D Marino, et al.
British Journal of Cancer|April 28, 2006
Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancerG L Banna, S M L Aversa, G Crivellari, et al.
Cancer Treatment Reports|May 1, 1982
Vindesine overdoseM V Fiorentino, L Salvagno, V Chiarion Sileni, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1983
Treatment of multiple myeloma with M-2 protocol and without maintenance therapyA Paccagnella, G Cartei, V Fosser, et al.
Tumori|June 30, 1984
Urinary hydroxyproline in multiple myeloma: correlation with clinical stages and bone diseaseS Bolzonella, A Paccagnella, L Salvagno, et al.
Tumori|December 31, 1985
Vindesine in plasma cell tumorsL Salvagno, A Paccagnella, V Chiarion Sileni, et al.
Pageof 5